Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by alnovaon May 27, 2018 3:19pm
218 Views
Post# 28086267

Clinical Trial

Clinical TrialLatest update to clinicaltrials.gov website is May 21,2018 and shows Estimated Study Start Date as May.2018. But also shows Recruitment Status as Not Yet Recruiting. We're almost closing out on May, so it would be nice to hear from the Company itself as to when they actually expect to get the trial under way, and why there would be any more delays, as they now have FDA approval as well as the Independant Review Board go ahead. I believe any more delays moving forward and lack of information for investors may further negatively affect share price. As an investor, I hope things get under way very soon, and that investors are provided timely updates as to progress with trial as well as any buisness developments. Good Luck to all SVA shareholders.


https://clinicaltrials.gov/ct2/show/study/NCT03513939#contacts
Bullboard Posts